Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Operating Expenses | 6,616 | 8,819 | 8,096 | 7,862 | 7,196 |
| Operating Income | -6,616 | -8,819 | -8,096 | -7,862 | -7,196 |
| Other Income | 115 | 196 | 397 | 539 | 650 |
| Pre-tax Income | -6,501 | -8,623 | -7,699 | -7,323 | -6,545 |
| Net Income Continuous | -6,501 | -8,623 | -7,699 | -7,323 | -6,545 |
| Net Income | $-6,501 | $-8,623 | $-7,699 | $-7,323 | $-6,545 |
| EPS Basic Total Ops | -46.48 | -61.47 | -68.97 | -52.47 | -46.48 |
| EPS Basic Continuous Ops | -45.91 | -60.90 | -70.86 | -51.80 | -46.32 |
| EPS Diluted Total Ops | -46.48 | -61.47 | -68.97 | -52.47 | -46.48 |
| EPS Diluted Continuous Ops | -45.91 | -60.90 | -70.86 | -51.80 | -46.32 |
| EBITDA(a) | $-6,516 | $-8,730 | $-8,009 | $-7,699 | $-7,082 |